Cyclophosphamide Structural Formula (Image 01)
Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-957
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cyclophosphamide Representative Container Label Ndc 10019-955-50 (Image 02)
This is a description of Cyclophosphamide, a cytotoxic agent used for injection in single dose sterile, non-pyrogenic parenteral use. It is manufactured by Baxter and each vial contains 500mg of the drug. For IV infusion, it should be dissolved in 25 mL sterile water and for direct injection use, it should be dissolved in 25 mL of 0.9% Sodium Chloride Injection. Storage instructions are included, as well as the NDC code 10019-955-50. The insert should be consulted for dosage recommendations and indications.*
Cyclophosphamide Representative Carton Label Ndc 10019-955-01 1 Of 2 (Image 03)
This is a description for a medical product called Cyclophosphamide. It is used as a cytotoxic agent and comes in form of a single dosage vial. The vial contains 500mg of Cyclophosphamide and needs to be diluted before injecting it to a patient. For intravenous infusion use, 25 mL stere Water for Injection, USP must be added and for direct injection use, 25 mL 0.9% Sodium Chloride Injection, USP must be added. It is important to store the vial at or below 25°C (17°F) and it should not be prescribed without thorough knowledge of dose, indications, and toxicity as contained in the accompanying literature. Manufacturing company information is included.*
Cyclophosphamide Representative Carton Label Ndc 10019-955-01 2 Of 2 (Image 04)
This is a description of a medication with the NDC code 10019-955-01. The medication is Cyclophosphamide injection, USP which comes in a single-dose vial with 500mg/vial. It must be diluted and used for IV infusion or direct injection. The medication is manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA, and was made in Germany.*
Cyclophosphamide Representative Container Label Ndc 10019-956-16 (Image 05)
This is a description of a medication called Cyclophosphamide for Injection, which comes in 1 gram/vial. It is considered a cytotoxic agent and is for single-dose use only. It is sterile, non-pyrogenic, and for parenteral use. It is manufactured by Baxter and made in Germany. Each vial contains 1g of Cyclophosphamide. For IV Infusion use, it should be diluted in sterile water for injection, and for direct injection use, it should be diluted in 0.9% sodium chloride injection. The medication is used for indications and dosage prescribed by a doctor. The vials should be stored at or below 25 degrees Celsius.*
Cyclophosphamide Representative Carton Label Ndc 10019-956-01 1 Of 2 (Image 06)
This text describes a medication called "Cyclophosphamide" for injection, with a concentration of 1 gram per vial. The vial must be diluted for use through intravenous infusion or direct injection. The manufacturer is Baxter Healthcare Corporation, based in Deerfield, IL, USA, and the product is made in Germany. The instructions recommend adding 50 ml sterile water for IV infusion use or 50 ml of 0.9% sodium chloride injection for direct injection use. The medication is a cytotoxic agent and for single-use only. The dosage must be administered with a thorough knowledge of the dose, indications, and toxicity as outlined in accompanying literature. The vial should be stored at temperatures below 25°C.*
Cyclophosphamide Representative Carton Label Ndc 10019-956-01 2 Of 2 (Image 07)
This is a description of a drug called Cyclophosphamide in the form of injection which comes in a 1-gram vial. The NDC number of the product is 10019-956-01, and it is manufactured by Baxter Healthcare Corporation. The drug must be diluted before use with IV infusion or direct injection. The product is a single-dose vial and is made in Germany.*
Cyclophosphamide Representative Container Label Ndc 10019-957-11 (Image 08)
This is a description of a medication called Cyclophosphamide, which comes in a 2 gram/vial for single dose use for intravenous infusion or direct injection. It is a sterile, non-pyrogenic and cytotoxic agent for parenteral use. The manufacturer is Baxter Healthcare Corporation in Deerfield, Illinois. It is recommended to add either sterile water for injection, USP, or 0.9% Sodium Chloride Injection, USP, to dissolve the drug. Dosage instructions are included in the insert provided, and the vial should be stored at 25°C (T7°F) or below.*
Cyclophosphamide Representative Carton Label Ndc 10019-967-01 1 Of 2 (Image 09)
Cyclophosphamide Representative Carton Label Ndc 10019-967-01 2 Of 2 (Image 10)
Cyclophosphamide for Injection is a USP drug that is available in a single-dose vial of 2 gram per vial. The drug can be used for IV infusion or direct injection use but must be diluted prior to use. The manufacturers of the drug are Baxter and BacerHestheare Corporation. The drug is manufactured in USA and Germany. The NDC codes for the drug are 10018-957-01 and 10019-957-01.*
Image 11
Baxter Cyclophosphamide for Injection is a medication sold in packs of 120 containing single dose vials of 500 mg each. It is manufactured by Baxter Healthcare Corporation and is to be stored at or below 25°C. The product has an expiration date and a lot number listed on the packaging. There is also a product identification number and a manufacturer's identification number included. The remaining characters appear to be a string of numbers and letters that do not provide any clear information about the product.*
Image 12
Image 13
This is a packaging for Cyclophosphamide for Injection, USP 1 g manufactured by Baxter Healthcare Corporation. The package consists of 120 single-dose vials, with instructions to store at or below 25°C (77°F). The stated IND code is 10019-956-01 and the labeling includes an expiration date (MMM JJJJ), lot number (JMXXXA) and quantity (QTY: 00). There are several numeric codes printed on the packaging, including (17) 000000, (10) JMXXXA, (30) 00, and (01)50310019956010, but it is unclear what these represent.*
Image 14
Baxter Cyclophosphamide for Injection is a medication supplied in 120 packs, each containing 1 x 1 g single-dose vials. The medication is manufactured by Baxter Healthcare Corporation and should be stored at or below 25°C (77°F). The package includes the drug's INDC code, expiration date (MMM JJJJ), lot number (JMXXXA), and quantity (QTy: 00). However, the last line of the text appears to be non-sensical and unreadable.*
Image 15
This is a description of Baxter's Cyclophosphamide for Injection medication. It is a 2g single dose vial that should be stored at or below 25°C (77°F). The product has a unique code and was manufactured by Baxter Healthcare Corporation in Deerfield, IL USA. The expiration date is present and it comes in packs of 60.*
Image 16
Cyclophosphamide is a medication used for chemotherapy. This particular product is in the form of an injection and contains 2 grams of Cyclophosphamide. It comes in packs of 60, with each pack having a single dose vial. It is manufactured by Baxter Healthcare Corporation, based in Deerfield, USA. The medication should be stored at or below 25°C (77°F). The product has a lot number (JMXXXA) and an expiration date, but the text does not specify them. Lastly, the text includes a National Drug Code (NDC), which is a unique identifier for drugs in the United States.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
